A new blood test based on 10 "biomarker" proteins will make it possible to test new treatments at an early stage of Alzheimer's progression.
Writing in the journal Alzheimer's & Dementia, researchers from King's College London describe how they investigated 26 proteins previously associated with Alzheimer's disease.
They analysed blood samples from 476 confirmed Alzheimer's patients, 220 individuals with "mild cognitive impairment" (MCI) who experienced occasional memory loss, and 450 healthy elderly people.
In the vast majority of cases, memory lapses do not lead to Alzheimer's. But the researchers identified 10 blood proteins that appeared in 87% of MCI patients diagnosed with the disease within a year.
More top news
Animal rights group PETA seizes 'teachable moment', warning Pokémon Go users the game is akin to animal cruelty.
A Labour MP has accused aides to Jeremy Corbyn and John McDonnell of a 'violation of privacy, security and confidentiality'.
Hate crime offenders face being slapped with tougher sentences after a surge in reports of abuse and attacks following the EU referendum.